Norma Bloy
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- interferon and immune responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 6
- Cancer Cells and Metastasis 4
- PARP inhibition in cancer therapy 4
- Immunology 22
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 7
- interferon and immune responses 6
- Co-authors
- Lorenzo Galluzzi (31 shared papers)Aitziber Buqué (26 shared papers)Guido Kroemer (24 shared papers)Laurence Zitvogel (15 shared papers)Alexander Eggermont (13 shared papers)Jérôme Galon (13 shared papers)Isabelle Cremer (12 shared papers)Jitka Fučíková (11 shared papers)
- Journals
- OncoImmunology (18 papers)Clinical Cancer Research (1 paper)Seminars in Cancer Biology (1 paper)Journal of Visualized Experiments (1 paper)Journal of Translational Medicine (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Norma Bloy
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Immunology 841
- Oncology 776
- Biotechnology 84
- Cancer Research 117
- Physiology 34
Countries citing papers authored by Norma Bloy
This map shows the geographic impact of Norma Bloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Bloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Bloy more than expected).
Fields of papers citing papers by Norma Bloy
This network shows the impact of papers produced by Norma Bloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Bloy. The network helps show where Norma Bloy may publish in the future.
Co-authors
The 25 scholars most cited alongside Norma Bloy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 234 | |
| 2 | 2015 | 108 | |
| 3 | 2015 | 103 | |
| 4 | 2019 | 99 | |
| 5 | 2015 | 95 | |
| 6 | 2015 | 92 | |
| 7 | 2015 | 91 | |
| 8 | 2014 | 80 | |
| 9 | 2016 | 67 | |
| 10 | 2014 | 64 | |
| 11 | 2014 | 47 | |
| 12 | 2016 | 47 | |
| 13 | 2015 | 44 | |
| 14 | 2016 | 43 | |
| 15 | 2015 | 40 | |
| 16 | 2021 | 36 | |
| 17 | 2015 | 32 | |
| 18 | 2015 | 27 | |
| 19 | 2016 | 18 | |
| 20 | 2014 | 16 |
About Norma Bloy
Norma Bloy is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers), interferon and immune responses (6 papers), Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Immunology (841 citations), Oncology (776 citations), Biotechnology (84 citations), Cancer Research (117 citations) and Physiology (34 citations). Norma Bloy has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Lorenzo Galluzzi, Aitziber Buqué, Guido Kroemer, Laurence Zitvogel, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Jitka Fučíková, Radek Špíšek and Fernando Aranda. Their work appears in journals such as OncoImmunology, Clinical Cancer Research, Seminars in Cancer Biology, Journal of Visualized Experiments and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.